Private Wealth Management Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Private Wealth Management Group’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-27	Closed	-$1.59K	–	1610
2023 Q4	$1.59K	Buy	+27	New	+$1.52K	﹤0.01%	1081

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Private Wealth Management Group's MRTX Position: Q1 2024 in Review

Private Wealth Management Group sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 27 shares — an estimated $1.59K sold.

Private Wealth Management Group first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.59K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Private Wealth Management Group reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Private Wealth Management Group sold 27 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.59K.
Private Wealth Management Group first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Private Wealth Management Group's Mirati Therapeutics, Inc. Common Stock position peaked at $1.59K in Q4 2023.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Private Wealth Management Group's 13F filing for Q1 2024, filed 30 Apr 2024.